Fentanyl theft at Urduliz Hospital triggers health alarm

Health Minister Gotzone Sagardui expresses concern over the disappearance of a high-risk drug amid ongoing investigations

The disappearance of fentanyl from Urduliz Hospital has enabled the health alarms in Bizkaia. Acting Health Minister Gotzone Sagardui has expressed her “concern” over the theft of this powerful opioid analgesic, which is considered “high risk”. During a recent press conference in Bilbao, Sagardui underlined the seriousness of the incidentbearing in mind that there is an ongoing investigation, both by the Ertzaintza and internally by Osakidetza.

As Sagardui explained, the theft was discovered during the usual checks that Osakidetza carries out on products considered high risk. “A discrepancy was identified between what was recorded in the register and what was actually present in the warehouse”the counsel detailed, adding that this has prompted an in-depth investigation to clarify the facts.

Fentanyl theft at Urduliz Hospital triggers health alarmRobo de fentanilo y Hospital de Urduliz despierta alarma sanitaria

Counsel emphasized the seriousness of the matter and emphasized that “We are responsible for these substances and their misuse is of great concern”. This incident highlights the importance of strict controls and careful investigation to prevent and clarify similar situations.

The consequences of the theft of fentanyl and the measures taken by the authorities to ensure health protection in Bizkaia

Fentanyl, a synthetic opioid primarily used to treat severe pain, is known for its high potency and risk of abuse. This drug, hundreds of times stronger than morphine, can have devastating consequences if it falls into the wrong hands.

Sagardui emphasized that after the disappearance of fentanyl was discovered, Osakidetza then filed the corresponding complaint with the Ertzaintza, which is currently leading the investigation.. “There is an ongoing investigation during which the testimonies, documents and processes necessary to clarify the facts will be established,” the counsel said.

At the same time, an internal investigation has been launched at Osakidetza to identify possible shortcomings in the control and storage procedures for hazardous substances. This double approach, both judicial and internalis committed to ensuring that all necessary measures are taken to prevent future similar incidents.

In addition to the formal complaint, internal policies and procedures regarding the handling of controlled substances are reviewed. These actions reflect the commitment of Osakidetza and the Euskadi Ministry of Health with the safety and well-being of the population.

Safety considerations in the management of high-risk medicines and the need for stricter controls

This incident at Urduliz Hospital is a stark reminder of the need to maintain strict controls and robust safety measures when handling high-risk drugs. The disappearance of fentanyl not only poses a potential public health hazard, but also highlights the vulnerability of healthcare systems to theft and misuse of controlled substances.

Sagardui emphasized that the safety and correct administration of these medications are critical. “It is clear that any situation in which a substance such as fentanyl, which is considered risky, does not correspond to its appropriate use, concerns us,” he concluded.

The advisor emphasized the responsibility of health authorities and health professionals to ensure that these incidents are not repeated. This not only implies the implementation of stricter preventive measures, but also a culture of surveillance constant and continuous improvement of medication management and control procedures.

The disappearance of fentanyl at Urduliz Hospital has highlighted the need to strengthen controls and safety measures in handling high-risk drugs. The ongoing investigations by the Ertzaintza and Osakidetza They reflect the authorities’ commitment to protecting public health and health safety in Bizkaia. This incident should serve as a call to action for all actors involved in the healthcare system, promoting safer and more responsible practices in the management of controlled substances.

Back To Top